Skip to main content

Table 2 Subject characteristics according to treatment groups

From: Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

  

Total

No treatment

Non-RAS treatment

RAS treatment

P-value

(N = 418)

(N = 136)

(N = 11)

(N = 271)

Median age

[IQR]

53[9]

53[11]

52[17]

53[9]

0.944a

Age

40–49

103(25 %)

40(29.4 %)

3(27.3 %)

60 (22.1 %)

 

50–59

233(56 %)

70(51.5 %)

4(36.4 %)

159(58.7 %)

0.268

60≤

82(20 %)

26(19.1 %)

4(36.4 %)

52(19.2 %)

 

Gender

Male

361(86 %)

122(89.7 %)

9(81.8 %)

230(84.9 %)

0.369

Female

57(14 %)

14(10.3 %)

2(18.2 %)

41(15.1 %)

Prefecture

Fukuoka

198(47 %)

72(52.9 %)

6(54.5 %)

121(44.6 %)

0.315

Median BMI, kg/m2

[IQR]

26.1[4.6]

26.2[44]

24.8[4.2]

26.1[4.6]

0.302a

Median WC, cm

[IQR]

90.3[13]

90.2[12.5]

87.5[10]

90.5[12.5]

0.368a

Median SBP, mmHg

[IQR]

142[19]

146[12]

139[31]

138[22]

0.001a

Median DBP, mmHg

[IQR]

88[14]

92[10]

82[20]

84[12]

0.001a

Median HbA1c, %

[IQR]

7.1[1.5]

7.4[1.8]

6.5[0.6]

7.1[1.5]

0.001a

Median TGs, mg/dl

[IQR]

139[106]

141.5[44]

139[73]

137[101]

0.94a

Median GGT, U/I

[IQR]

54[58]

46[49]

44[76]

57[57]

0.153a

Hypercholesterolemia

 

734(33 %)

337(30.4 %)

143(34.2 %)

151(32.7)

0.389

Smoking

 

493(22 %)

211(19 %)

93(22.2 %)

122(26.4)

0.821

  1. Numbers are median [IQR] or number (%), unless otherwise stated. IQR interquartile range
  2. BMI body mass index, WC waist circumference, TGs triglycerides, GGT gamma-glutamyltransferase
  3. aCompared using the Kruskal-Wallis test. Other comparisons made using Pearson's chi-square test